enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

3. Respiratory pharmacology - Wikipedia

   en.wikipedia.org/wiki/Respiratory_Pharmacology

   1.4 Anticholinergic (Parasympatholytic) Bronchodilators. ... There are several categories of respiratory drugs, each specific to a drug's purpose and mode of action.

4. Category:Antiasthmatic drugs - Wikipedia

   en.wikipedia.org/wiki/Category:Antiasthmatic_drugs

   These drugs are used for the treatment of asthma. They may be useful either in the treatment or prevention of asthma attacks. Subcategories.

5. Beta2-adrenergic agonist - Wikipedia

   en.wikipedia.org/wiki/Beta2-adrenergic_agonist

   They are primarily used to treat asthma and other pulmonary disorders. Bronchodilators are considered an important treatment regime for chronic obstructive pulmonary disease (COPD) and are usually used in combination with short acting medications and long acting medications in a combined inhaler. [1] [2]

6. Cholinergic blocking drug - Wikipedia

   en.wikipedia.org/wiki/Cholinergic_blocking_drug

   [25] [26] Below listed are some medications or food that can interact with anticholinergics. Medications indicated for: Irregular heartbeat, e.g. disopyramide, quinidine. Drug-induced arrhythmia worsened by anticholinergics' side effect of tachycardia. Parkinson's disease, e.g. levodopa. Atropine decreases the absorption of levodopa.

7. Long-acting beta-adrenoceptor agonist - Wikipedia

   en.wikipedia.org/wiki/Long-acting_beta...

   The proposed mechanism is that while LABAs relieve asthma symptoms, they can also promote bronchial inflammation and sensitivity without warning. [23] On February 18, 2011, the FDA issued a safety alert for long-acting β agonists. [24]